Skip to main content
Premium Trial:

Request an Annual Quote

VWR Buys Biochemical, Reagent Firm Amresco

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – VWR International today announced the acquisition of Amresco for an undisclosed amount.

Based in Solon, Ohio, Amresco manufactures and supplies biochemicals and reagents for use in research in the molecular biology, life sciences, proteomics, clinical, and histology markets.

The addition of Amresco expands VWR's product portfolio, Matt Malenfant, VWR senior vice president and president of North America, Lab Business and Services, said in a statement. He added that Amresco's "expertise plays well with our increased focus on chemical and life science applications and will provide our customers greater choice and value."

VWR is a global laboratory supply and distribution firm based in Radnor, Penn. It generated worldwide sales of $3.5 billion in 2009.

The Scan

Support for Moderna Booster

An FDA advisory committee supports authorizing a booster for Moderna's SARS-CoV-2 vaccine, CNN reports.

Testing at UK Lab Suspended

SARS-CoV-2 testing at a UK lab has been suspended following a number of false negative results.

J&J CSO to Step Down

The Wall Street Journal reports that Paul Stoffels will be stepping down as chief scientific officer at Johnson & Johnson by the end of the year.

Science Papers Present Proteo-Genomic Map of Human Health, Brain Tumor Target, Tool to Infer CNVs

In Science this week: gene-protein-disease map, epigenomic and transcriptomic approach highlights potential therapeutic target for gliomas, and more